METHYLPHENIDATE ER(LA) 30 MG CP

Methylphenidate Hydrochloride
$2.0778per EA
DEA Schedule CII

Strength

30 mg/1

NDC

75907005101

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078458

On Market Since

12/20/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-1.3%

3M

-10.8%

6M

-20.2%

1Y

-29.0%

3Y

N/A

5Y

N/A

All

+6.0%